2 min read
ASH Annual Meeting and Exposition
Meet Veristat at ASH Meeting and Exposition December 6-9, 2025
Veristat is excited to attend the ASH Annual Meeting and...
Veristat is excited to attend the ASH Annual Meeting and Exposition, the world’s premier event for cutting-edge research in malignant and non-malignant hematology. This year’s meeting will take place December 6–9, 2025, bringing together global experts to share groundbreaking research and clinical advances in blood disorders.
Gabriela Rosu, M.D., Veristat’s Vice President of Global Medical Affairs and Pharmacovigilance, will be attending ASH 2025. Connect with Gabriela to explore how Veristat’s integrated medical, regulatory, and safety expertise can help accelerate your hematology programs.
Want to schedule a meeting in advance? Complete the form to reserve time with Gabriela.
At Veristat, we understand that every day matters in oncology and hematology drug development. Our multidisciplinary teams bring scientific rigor, regulatory insight, and operational excellence to complex oncology programs, including rare cancers, hematologic malignancies, and gene or cell therapies.
Our expertise spans:
Adaptive and biomarker-driven trial designs
Regulatory and statistical strategy for oncology submissions
Global operations for rare and hematologic cancer studies
With more than 480 oncology and hematology studies and 30+ marketing applications supported in the past five years, Veristat helps sponsors turn promising science into approved therapies faster.
Meet Us at the Show
We look forward to seeing you at ASH 2025 and exploring how Veristat can help accelerate your hematology and oncology innovations.
Date: December 6-9, 2025
Location: Orlando FL
Meet with us at ASH Annual Meeting and Exposition
2 min read
Oct 22, 2025 Veristat Events
Veristat is excited to attend the ASH Annual Meeting and...
2 min read
Oct 17, 2025 Veristat Events
Veristat is proud to participate...